The IL-13Rα2 is overexpressed in 75% of GBM malignant cells and is involved in the activation of the phosphatidylinositol 3-kinase/AKT/mammalian target of rapamycin pathway [67]. This evidence concerns the gene IL13RA2 and glioblastoma.